HSBC Holdings
ASMB icon

HSBC Holdings’s Assembly Biosciences ASMB Stock Holding History

HSBC Holdings’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-951
Closed -$9.42K – 3046
2023
Q4 		$9.42K Hold
951
– – ﹤0.01% 2692
2023
Q3 		$10.2K Hold
951
– – ﹤0.01% 2682
2023
Q2 		$12.8K Hold
951
– – ﹤0.01% 2531
2023
Q1 		$9.53K Hold
951
– – ﹤0.01% 2623
2022
Q4 		$14.3K Sell
951
-56
-6% -$957 ﹤0.01% 3025
2022
Q3 		$20K Sell
1,007
-200
-17% -$4.84K ﹤0.01% 2872
2022
Q2 		$31K Sell
1,207
-347
-22% -$7.99K ﹤0.01% 3172
2022
Q1 		$38K Hold
1,554
– – ﹤0.01% 3213
2021
Q4 		$44K Buy
+1,554
New +$51K ﹤0.01% 3208
2019
Q4 		– Sell
-2,347
Closed -$277K – 3026
2019
Q3 		$277K Buy
+2,347
New +$355K ﹤0.01% 2673
2018
Q3 		– Sell
-871
Closed -$410K – 2532
2018
Q2 		$410K Sell
871
-788
-47% -$417K ﹤0.01% 2149
2018
Q1 		$978K Sell
1,659
-1,707
-51% -$1.06M ﹤0.01% 1646
2017
Q4 		$1.83M Buy
+3,366
New +$1.52M ﹤0.01% 1140
2017
Q2 		– Sell
-674
Closed -$206K – 2183
2017
Q1 		$206K Buy
+674
New +$165K ﹤0.01% 1987

Other funds holding ASMB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HSBC Holdings's ASMB Position: Q1 2024 in Review

HSBC Holdings sold out of Assembly Biosciences (ASMB) in Q1 2024, closing a stake of 951 shares — an estimated $9.42K sold.

HSBC Holdings first reported a position in ASMB in Q1 2017 and held it in 14 quarters. The position peaked at $1.83M in Q4 2017. 24 funds tracked by Wall St. Rank hold ASMB as of Q1 2024.

  • HSBC Holdings reported no remaining Assembly Biosciences position as of Q1 2024 after selling out during the quarter.
  • HSBC Holdings sold 951 Assembly Biosciences shares in Q1 2024, an estimated $9.42K.
  • HSBC Holdings first reported a position in Assembly Biosciences in Q1 2017 and held it in 14 quarters.
  • HSBC Holdings's Assembly Biosciences position peaked at $1.83M in Q4 2017.
  • 24 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2024.

Based on HSBC Holdings's 13F filing for Q1 2024, filed 15 May 2024.